> Given that the NHS lists most of the meds discussed so far as approved treatments [https://www.nsh.uk/conditions/hepatitis-c/treatment] and Hep C is been a target for increased treatment by the NHS for the past two years I am wondering what you base your claim that it is easier for US citizens to get access to the drugs than it is in the UK?

"Approved treatments" just means "there exists a circumstance under which the NHS will cover them". For starters, the NHS almost never treats patients in acute stages of infection, whereas insurers in the US don't distinguish between acute and chronic infections. The NHS also tries to force patients to use interferon-based treatment first before covering the newer medications. There are ways around that, but it's not simple or easy.